Functional immune mapping with deep-learning enabled phenomics applied to immunomodulatory and COVID-19 drug discovery
Michael F. Cuccarese, Berton A. Earnshaw, Katie Heiser et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020
ABSTRACT Development of accurate disease models and discovery of immune-modulating drugs is challenged by the immune system’s highly interconnected and context-dependent nature. Here we apply deep-learning-driven analysis of cellular morphology to develop a scalable “phenomics” platform and demonstrate its ability to identify dose-dependent, high-dimensional relationships among and between immunomodulators, toxins, pathogens, genetic perturbations, and small and large molecules at scale. High-throughput screening on this platform demonstrates rapid identification and triage of hits for TGF-β- and TNF-α-driven phenotypes. We deploy the platform to develop phenotypic models of active SARS-CoV-2 infection and of COVID-19-associated cytokine storm, surfacing compounds with demonstrated clinical benefit and identifying several new candidates for drug repurposing. The presented library of images, deep learning features, and compound screening data from immune profiling and COVID-19 screens serves as a deep resource for immune biology and cellular-model drug discovery with immediate impact on the COVID-19 pandemic.
Cited by 47 works. doi:10.1101/2020.08.02.233064 Open-access PDF
Authors
- Michael F. Cuccarese
- Berton A. Earnshaw
- Katie Heiser
- Ben Fogelson
- Chadwick T. Davis
- Peter McLean
- Kathleen-Rose Skelly
- Fiona L. Weathersby
- Vlad Rodic
- Ian K. Quigley
- Elissa D. Pastuzyn
- Brandon M. Mendivil
- Nathan H. Lazar
- Carl Brooks
- Brandon Probst
- Pamela Jacobson
- Seth Glazier
- Jes Ford
References
- Densely Connected Convolutional Networks
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- Remdesivir for the Treatment of Covid-19 — Final Report
- CellProfiler: image analysis software for identifying and quantifying cell phenotypes
- ArcFace: Additive Angular Margin Loss for Deep Face Recognition
- The trinity of COVID-19: immunity, inflammation and intervention
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- NF-κB signaling in inflammation
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease